Skip to main content
Orphanet Journal of Rare Diseases logoLink to Orphanet Journal of Rare Diseases
. 2019 May 10;14:104. doi: 10.1186/s13023-019-1084-7

Correction to: Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome – new data and literature review

James F H Pittaway 1,, Christopher Harrison 2, Yumie Rhee 3, Muriel Holder-Espinasse 4, Alan E Fryer 5, Tim Cundy 6, William M Drake 1, Melita D Irving 4
PMCID: PMC6509852  PMID: 31077240

Correction to: Orphanet J Rare Dis

https://doi.org/10.1186/s13023-018-0795-5

After publication of this article [1], it is noticed reference no. 17 was incorrectly provided, details are shown below:

Original reference no. 17:

Canalis E, Schilling L, Yee SP, Lee SK, Zanotti S. Hajdu Cheney mouse mutants exhibit osteopenia, increased Osteoclastogenesis, and bone resorption. J Biol Chem. 2016;291(4):1538–51. 10.1074/jbc. M115.685453.

Correct reference no. 17:

G. Adami, M. Rossini, D. Gatti, G. Orsolini, L. Idolazzi, O. Viapiana, A. Scarpa, E. Canalis Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab Bone, 92 (2016), pp. 150–156.

The author apologizes for the inconvenience caused.

Reference

  • 1.Pittaway, et al. Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome – new data and literature review. Orphanet J Rare Dis. 2018;13:47. doi: 10.1186/s13023-018-0795-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Orphanet Journal of Rare Diseases are provided here courtesy of BMC

RESOURCES